Pretreatment with angiotensin-converting enzyme inhibitor improves doxorubicin-induced cardiomyopathy via preservation of mitochondrial function

Journal of Thoracic and Cardiovascular Surgery

Volumn 142, Issue 2, 2011, Pages 396-

  Hiona, Asimina ^a   Lee, Andrew Stephen ^a   Nagendran, Jayan ^a   Xie, Xiaoyan ^a   Connolly, Andrew J ^a   Robbins, Robert C ^a   Wu, Joseph C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CASPASE 3; CASPASE 9; DOXORUBICIN; ENALAPRIL; FREE RADICAL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDIOMYOPATHY; CELL LEVEL; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; CYTOSOLIC FRACTION; DRUG MECHANISM; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE CONTRACTILITY; HEART MITOCHONDRION; IN VIVO STUDY; MITOCHONDRIAL RESPIRATION; MONOTHERAPY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RAT; UPREGULATION;

EID: 79960394760     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2010.07.097     Document Type: Article

References (29)

1. G. Sacco, M. Bigioni, S. Evangelista, C. Goso, S. Manzini, and C.A. Maggi Cardioprotective effects of zofenopril, a new angiotensin-converting enzyme inhibitor, on doxorubicin-induced cardiotoxicity in the rat Eur J Pharmacol 414 2001 71 78 (Pubitemid 32174877)
2. S.E. Lipshultz, J.A. Alvarez, and R.E. Scully Anthracycline associated cardiotoxicity in survivors of childhood cancer Heart 94 2008 525 533 (Pubitemid 351441417)
3. S. Zhou, A. Starkov, M.K. Froberg, R.L. Leino, and K.B. Wallace Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin Cancer Res 61 2001 771 777 (Pubitemid 32128645)
4. N. Siveski-Iliskovic, N. Kaul, and P.K. Singal Probucol promotes endogenous antioxidants and provides protection against Adriamycin-induced cardiomyopathy in rats Circulation 89 1994 2829 2835 (Pubitemid 24173705)
5. E.A. Konorev, M.C. Kennedy, and B. Kalyanaraman Cell-permeable superoxide dismutase and glutathione peroxidase mimetics afford superior protection against doxorubicin-induced cardiotoxicity: the role of reactive oxygen and nitrogen intermediates Arch Biochem Biophys 368 1999 421 428 (Pubitemid 29406570)
6. M.A. Pfeffer, E. Braunwald, L.A. Moye, L. Basta, E.J. Brown Jr., and T.E. Cuddy Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators N Engl J Med 327 1992 669 677
7. R.J. Boucek Jr., A. Steele, A. Miracle, and J. Atkinson Effects of angiotensin-converting enzyme inhibitor on delayed-onset doxorubicin-induced cardiotoxicity Cardiovasc Toxicol 3 2003 319 329 (Pubitemid 38055999)
8. D. Cardinale, A. Colombo, M.T. Sandri, G. Lamantia, N. Colombo, and M. Civelli Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition Circulation 114 2006 2474 2481 (Pubitemid 44901520)
9. D. Cardinale, A. Colombo, G. Lamantia, N. Colombo, M. Civelli, and G. De Giacomi Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy J Am Coll Cardiol 55 2010 213 220
10. J.A. Tallaj, V. Franco, B.K. Rayburn, L. Pinderski, R.L. Benza, and S. Pamboukian Response of doxorubicin-induced cardiomyopathy to the current management strategy of heart failure J Heart Lung Transplant 24 2005 2196 2201 (Pubitemid 41814746)
11. C. Richard, B. Lauzier, S. Delemasure, S. Talbot, S. Ghibu, and B. Collin Effects of angiotensin-1 converting enzyme inhibition on oxidative stress and bradykinin receptor expression during doxorubicin-induced cardiomyopathy in rats J Cardiovasc Pharmacol 52 2008 278 285
12. A. Sanbe, K. Tanonaka, R. Kobayasi, and S. Takeo Effects of long-term therapy with ACE inhibitors, captopril, enalapril and trandolapril, on myocardial energy metabolism in rats with heart failure following myocardial infarction J Mol Cell Cardiol 27 1995 2209 2222
13. G. Barja The quantitative measurement of H2O2 generation in isolated mitochondria J Bioenerg Biomembr 34 2002 227 233 (Pubitemid 34847805)
14. M.A. Abd El-Aziz, A.I. Othman, M. Amer, and M.A. El-Missiry Potential protective role of angiotensin-converting enzyme inhibitors captopril and enalapril against Adriamycin-induced acute cardiac and hepatic toxicity in rats J Appl Toxicol 21 2001 469 473 (Pubitemid 33130747)
15. W. Zhu, M.H. Soonpaa, H. Chen, W. Shen, R.M. Payne, and E.A. Liechty Acute doxorubicin cardiotoxicity is associated with p53-induced inhibition of the mammalian target of rapamycin pathway Circulation 119 2009 99 106
16. K. LaNoue, W.J. Nicklas, and J.R. Williamson Control of citric acid cycle activity in rat heart mitochondria J Biol Chem 245 1970 102 111
17. H. Nojiri, T. Shimizu, M. Funakoshi, O. Yamaguchi, H. Zhou, and S. Kawakami Oxidative stress causes heart failure with impaired mitochondrial respiration J Biol Chem 281 2006 33789 33801 (Pubitemid 46036756)
18. A. Sanz, P. Caro, J. Ibanez, J. Gomez, R. Gredilla, and G. Barja Dietary restriction at old age lowers mitochondrial oxygen radical production and leak at complex I and oxidative DNA damage in rat brain J Bioenerg Biomembr 37 2005 83 90 (Pubitemid 40768569)
19. X. Liu, Z. Chen, C.C. Chua, Y.S. Ma, G.A. Youngberg, R. Hamdy, and B.H. Chua Melatonin as an effective protector against doxorubicin-induced cardiotoxicity Am J Physiol Heart Circ Physiol 283 2002 H254 H263
20. R. Ader, K. Chatterjee, T. Ports, B. Brundage, B. Hiramatsu, and W. Parmley Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor Circulation 61 1980 931 937 (Pubitemid 10147079)
21. A. Ascensao, J. Magalhaes, J.M. Soares, R. Ferreira, M.J. Neuparth, and F. Marques Moderate endurance training prevents doxorubicin-induced in vivo mitochondriopathy and reduces the development of cardiac apoptosis Am J Physiol Heart Circ Physiol 289 2005 H722 H731
22. L.E. Solem, T.R. Henry, and K.B. Wallace Disruption of mitochondrial calcium homeostasis following chronic doxorubicin administration Toxicol Appl Pharmacol 129 1994 214 222 (Pubitemid 24380792)
23. K.B. Wallace Doxorubicin-induced cardiac mitochondrionopathy Pharmacol Toxicol 93 2003 105 115 (Pubitemid 37108538)
24. S.M. Davidson, and M.R. Duchen Endothelial mitochondria: contributing to vascular function and disease Circ Res 100 2007 1128 1141 (Pubitemid 46684126)
25. A.K. Doughan, D.G. Harrison, and S.I. Dikalov Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction Circ Res 102 2008 488 496 (Pubitemid 351651106)
26. A. Sanbe, K. Tanonaka, R. Kobayasi, and S. Takeo Effects of long-term therapy with ACE inhibitors, captopril, enalapril and trandolapril, on myocardial energy metabolism in rats with heart failure following myocardial infarction J Mol Cell Cardiol 27 1995 2209 2222
27. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 1976 248 254
28. G. Barja The quantitative measurement of H2O2 generation in isolated mitochondria J Bioenerg Biomembr 34 2002 227 233 (Pubitemid 34847805)
29. G. Barja Mitochondrial oxygen radical generation and leak: sites of production in states 4 and 3, organ specificity, and relation to aging and longevity J Bioenerg Biomembr 31 1999 347 366 (Pubitemid 30058570)